AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Sjögren Syndrome

B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome NCT04931160NA1 site📍 Brest University Hospital, Brest · Tests: Blood, fluid, sells and urine samples Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine NCT06528197n/a1 site📍 Beijing China-Japan Friendship Hospital Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden NCT07621809Phase 333 sites📍 Peoria📍 Clearwater📍 Tampa Novartis Pharmaceuticals · Tests: VAY736, Placebo Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases NCT07246096EARLY Phase 11 site📍 Shanghai Changhai Hospital · Tests: anti-CD19/BCMA U CAR T cells Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Imaging NCT07324733NA1 site📍 Beijing Peking Union Medical College Hospital · Tests: ⁶⁸Ga-PSMA PET/CT, ⁶⁸Ga-FAPI PET/CT Dental and Periodontal Status of Patients With Sjögren's Syndrome. NCT04848870n/a1 site📍 Ivry-sur-Seine Assistance Publique - Hôpitaux de Paris · Tests: Salivary samples A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease NCT07041099Phase 114 sites📍 Orlando📍 Brooklyn📍 Memphis Cullinan Therapeutics Inc. · Tests: CLN-978 New Clinical End-points in Patients With Primary Sjögren's Syndrome NCT05113004Phase 27 sites📍 Brest📍 Lille📍 Montpellier Assistance Publique - Hôpitaux de Paris · Tests: Hydroxychloroquine 400mg/d, Leflunomide 20mg/d, Mycophenolate mofetil 2000mg/d, Placebo of Hydroxychloroquine 400mg/d, … Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy NCT03509064n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Collection sheet ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS NCT06593041n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database NCT04613089n/a1 site📍 Hamburg Universitätsklinikum Hamburg-Eppendorf · Tests: Natural History The Myelin Disorders Biorepository Project NCT03047369n/a23 sites📍 Los Angeles📍 Orange📍 Palo Alto Children's Hospital of Philadelphia
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy